System and method for detection of HIV integrase variants
Assignee454 Life Sciences Corporation
InventorsBirgitte Binderup Simen, Elizabeth Patricia St. John
Life of this patent
Estimating the term…
Loading patent…
Assignee454 Life Sciences Corporation
InventorsBirgitte Binderup Simen, Elizabeth Patricia St. John
Estimating the term…
An embodiment of a method for detecting low frequency occurrence of one or more HIV sequence variants associated with integrase is described that comprises the steps of: (a) generating a cDNA species from a plurality of RNA molecules in an HIV sample population; (b) amplifying a plurality of first amplicons from the cDNA species, wherein each first amplicon is amplified with a pair of nucleic acid primers; (c) clonally amplifying the amplified copies of the first amplicons to produce a plurality of second amplicons; (d) determining a nucleic acid sequence composition of the second amplicons; (e) detecting one or more sequence variants that occur at a frequency of 5% or less in the nucleic acid sequence composition of the second amplicons; and (f) correlating the detected sequence variants with variation associated with HIV integrase.
A method for detecting low frequency occurrence of one or more HIV sequence variants associated with integrase, comprising the steps of:
A kit for detecting one or more HIV sequence variants associated with the integrase region, comprising:
Dependencies are inferred from the claim text.